United Imaging Healthcare Announces Q3 2024 Results with Revenue of January to September of 6.95 Billion CNY
SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, announced its financial results for the third quarter of 2024. Reflecting its development strategy and strategic R&D investments, the company reported that revenue of January to September is 6.95 billion CNY, with net income attributable to...
Infinitus Products Received the Hong Kong Q-Mark Certificate
GUANGZHOU, China, Sept. 30, 2022 /PRNewswire/ -- The Q-Mark 43rd Anniversary cum Presentation Ceremony has been successfully held at the Hong Kong Convention and Exhibition Centre on 2 September 2022. Nine Infinitus Products Have Received the Hong Kong Q-Mark Product Certification. The Hong Kong Q-Mark Product Scheme companies with an effective quality management system that ensures production...
Zylox-Tonbridge Announces 2024 Annual Results: Achieves Full-Year Profit for the First Time with Net Profit Exceeding USD 14 Million
HANGZHOU, China, March 29, 2025 /PRNewswire/ -- On March 20, Zylox-Tonbridge Medical Technology Co., Ltd. (Stock Code: 2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") released its 2024 annual results. In 2024, the Company reported revenue of USD 109.4 million, a year-on-year increase of 48.3%, and achieved a net profit exceeding USD 14 million, marking its first full-year profitability....
Everlife acquires Research Instruments Group and other laboratory suppliers to boost presence in strategic life sciences and clinical diagnostics segments in South East Asia
SINGAPORE, March 10, 2022 /PRNewswire/ -- Everlife Holdings Pte Ltd ("Everlife"), a leading market access and distribution company in India and South East Asia, has announced the completion of its acquisition of Research Instruments Group ("RI"), a leading provider of scientific and laboratory instrumentation in Singapore, Malaysia, Thailand and Vietnam. Founded in...
Hugel launches botulinum toxin Letybo in Malaysia
- The company strengthens brand experience for local medical professionals through academic events and hands-on workshops - It will solidify the market position of premium toxin products through Malaysian partner Venusys Medical SEOUL, South Korea, Aug. 11, 2025 /PRNewswire/ -- Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha,...
Amorepacific Research Confirms Potential of Microalgal-Derived PDRNs in Skin Regeneration and Wound Healing
New findings suggest 'BluePDRN™' offers a sustainable, scalable alternative to traditional animal-derived PDRNs SEOUL, South Korea, April 29, 2025 /PRNewswire/ -- Amorepacific revealed research findings confirming the skin-regenerative effects of polydeoxyribonucleotides (PDRNs) extracted from a microalgal source, Chlorella protothecoides. The findings were published in the international journal Archives of Dermatological Research under the title, "Effects of Chlorella...
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that Prof. Weiming Li, of Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, has...
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer’s Disease Research
New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development. FREMONT, Calif., Oct. 10, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217...
Singapore-Johor VTL resumes with COVID-19 test results issued by Jebhealth
SINGAPORE, Feb. 8, 2022 /PRNewswire/ -- With the resumption of the land VTL between Singapore and Johor Bahru on Jan 21, about 2,000 travellers are expected to cross the causeway each day, in hope that we can eventually scale up to the normal 300,000 daily commutes. Many would be meeting their loved ones for the first time this year...
Innovent’s MSCI ESG Rating Upgraded to A
ROCKVILLE, Md. and SUZHOU, China, Nov. 30, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the Company has been upgraded to 'A' according to Morgan Stanley Capital International's (MSCI) latest ESG rating, ranking at the forefront...
